Macquarie tips substantial upside for Steadfast shares

Steadfast is a high-quality business at an attractive valuation, according to the broker.

Steadfast Group Ltd (ASX: SDF) shares have risen 76% over the past 5 years, handily beating the S&P/ASX 200 Index (ASX: XJO), which is up 42% over the same timeframe. 

Steadfast is Australia's largest general insurance broker and underwriting agency network. It focuses on small to medium enterprise (SME) businesses, which require the expertise of insurance brokers and agencies to assess and manage their commercial risks.

The ASX 200 insurance broker operates in a large and growing market. According to Grand View Research, the global insurance brokerage market was valued at US$287 billion in 2023. The North American market accounted for around 30% of this total. 

The global market is projected to grow at a compound annual growth rate of 9.2% between 2024 and 2030 to reach US$524 billion. This is likely to be driven by rising demand for insurance products as businesses face more frequent and severe catastrophic events.

Steadfast has a track record of expansion through strategic acquisitions. In 2024, it acquired 48 brokerage and underwriting agency businesses. This included ISU Group, a major network of independent agencies in the US, and Sure Insurance, a specialised underwriting agency. 

The insurance brokerage sector is highly fragmented. Its major competitor in Australia is AUB Group Ltd (ASX: AUB). In the US, it competes with the likes of Brown & Brown (NYSE: BRO) and Arthur J. Gallagher & Co (NYSE: AJG), which enjoy premium valuation multiples. 

Evidently, Steadfast has a lot going for it that could make it a much bigger business in the future.

But is it a good investment today?

Let's see what one broker had to say.

Business meeting to discuss buy now pay later platform

Image Source: Getty Images

Macquarie tips Steadfast to outperform

In a 3 July research note, broker Macquarie Group (ASX: MQG) reiterated its outperform rating on Steadfast shares. 

The broker has assigned a price target of $7.00 to the company. On Friday, Steadfast shares finished the trading session at $6.00. This suggests more than 20% upside from here, including both capital gains and dividends (Steadfast currently offers a dividend yield of 3.03%). 

When issuing this recommendation, the broker said:

Outperform. The ability to maximise returns on a US roll-out is key to SDF's long-term value. At current valuations, we retain our Outperform recommendation.

On the subject of valuation, Macquarie said Steadfast shares were currently very attractively valued relative to its international peers:

2-year forward PE multiple relative to international brokers: SDF is trading at a ~20.8% discount (vs a 2.3% long-term premium) to international brokers.

On the home front, the broker noted that it was trading at a premium relative to AUB, however, the gap had significantly narrowed from its historical levels:

2-year forward PE Rel SDF vs AUB: SDF is trading at a ~4.8% premium to AUB (compared with the ~11.6% long-term premium).

Foolish Takeaway

At a time when the ASX 200 is just below its all-time high, it may be challenging for investors to find quality businesses at attractive prices. Macquarie considers Steadfast shares to have an especially compelling valuation today.

Steadfast will release its full-year results for FY25 on 21 August. Stay tuned.

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Steadfast Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Arthur J. Gallagher & Co. The Motley Fool Australia has positions in and has recommended Macquarie Group and Steadfast Group. The Motley Fool Australia has recommended Aub Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two male ASX investors and executives wearing dark coloured suits sit at a table holding their mobile phones discussing the highest trading ASX 200 shares today
Broker Notes

Buy, hold, sell: Resmed, Goodman Group, CBA shares

We review three fresh buy, hold, and sell calls from John Athanasiou at Red Leaf Securities.

Read more »

colleagues on a lunch break looking at iPhone
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

7 ASX 200 shares in the buy zone as optimism returns to the market: experts

Brokers reaffirmed their buy calls on Liontown, Rio Tinto, Xero, and others this week.

Read more »